• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥司他韦修饰牛血清白蛋白抑制神经氨酸酶活性并聚集病毒粒子以干扰流感病毒复制。

Oseltamivir modified bovine serum albumin inhibits neuraminidase activity and accumulates virion particles to disturb influenza virus replication.

机构信息

Research Centre of Modern Analytical Technology, Tianjin University of Science & Technology, No. 29, 13th Avenue, TEDA, Tianjin, 300457, China.

China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science & Technology, No. 29, 13th Avenue, TEDA, Tianjin, 300457, China.

出版信息

Carbohydr Res. 2022 Oct;520:108631. doi: 10.1016/j.carres.2022.108631. Epub 2022 Jul 8.

DOI:10.1016/j.carres.2022.108631
PMID:35839640
Abstract

The preparation of oseltamivir-bovine serum albumin conjugate (OS-BSA) for use as a multivalent influenza neuraminidase (NA) inhibitor is reported. Briefly, the oseltamivir azidohexyl ester was synthesized and covalently bound via an orthogonal attachment to bicyclononyne-modified BSA using copper-free click chemistry. Primary antiviral assays on NA protein and cellular levels showed that the synthetic multivalent OS-BSA conjugate was a more effective inhibitor than monomeric OS azidohexyl ester. Further investigation of the antiviral mechanism found that the prepared OS-BSA could not only be used as a multivalent NA inhibitor but also acted as an adsorbent for the aggregation of virion particles, contributing to the inhibition of the influenza viral replication cycle. Our findings provide insight into the antiviral mechanism of multivalent NA inhibitors and form a basis for the development of novel antiviral agents.

摘要

报道了一种用于作为多价流感神经氨酸酶(NA)抑制剂的奥司他韦-牛血清白蛋白缀合物(OS-BSA)的制备。简要地说,通过无铜点击化学将奥司他韦叠氮己基酯通过正交连接共价结合到双环壬炔修饰的 BSA 上合成。在 NA 蛋白和细胞水平上的初步抗病毒测定表明,合成的多价 OS-BSA 缀合物比单体 OS 叠氮己基酯更有效。对抗病毒机制的进一步研究发现,所制备的 OS-BSA 不仅可以用作多价 NA 抑制剂,而且还可以作为病毒粒子聚集的吸附剂,有助于抑制流感病毒复制周期。我们的研究结果深入了解了多价 NA 抑制剂的抗病毒机制,并为新型抗病毒药物的开发奠定了基础。

相似文献

1
Oseltamivir modified bovine serum albumin inhibits neuraminidase activity and accumulates virion particles to disturb influenza virus replication.奥司他韦修饰牛血清白蛋白抑制神经氨酸酶活性并聚集病毒粒子以干扰流感病毒复制。
Carbohydr Res. 2022 Oct;520:108631. doi: 10.1016/j.carres.2022.108631. Epub 2022 Jul 8.
2
A Zanamivir-protein conjugate mimicking mucin for trapping influenza virion particles and inhibiting neuraminidase activity.一种模拟粘蛋白的扎那米韦蛋白缀合物,用于捕获流感病毒粒子并抑制神经氨酸酶活性。
Int J Biol Macromol. 2024 Aug;275(Pt 1):133564. doi: 10.1016/j.ijbiomac.2024.133564. Epub 2024 Jun 30.
3
Divalent oseltamivir analogues as potent influenza neuraminidase inhibitors.二价奥司他韦类似物作为有效的流感神经氨酸酶抑制剂。
Carbohydr Res. 2019 May 15;477:32-38. doi: 10.1016/j.carres.2019.03.012. Epub 2019 Apr 1.
4
Amide-sialoside protein conjugates as neomucin bioshields prevent influenza virus infection.酰胺唾液酸蛋白缀合物作为新型粘蛋白生物盾牌可预防流感病毒感染。
Carbohydr Res. 2020 Sep;495:108088. doi: 10.1016/j.carres.2020.108088. Epub 2020 Jun 26.
5
Preparation of eicosavalent triazolylsialoside-conjugated human serum albumin as a dual hemagglutinin/neuraminidase inhibitor and virion adsorbent for the prevention of influenza infection.制备二十价三唑基唾液酸糖缀合人血清白蛋白作为预防流感感染的双重血凝素/神经氨酸酶抑制剂和病毒吸附剂。
Carbohydr Res. 2023 Oct;532:108918. doi: 10.1016/j.carres.2023.108918. Epub 2023 Aug 4.
6
Chemoenzymatic synthesis of sialyl-α2,3-lactoside-functionalized BSA conjugate inhibits influenza infection.酶促化学法合成唾液酸-α2,3-乳糖基化 BSA 缀合物抑制流感感染。
Eur J Med Chem. 2024 Oct 5;276:116633. doi: 10.1016/j.ejmech.2024.116633. Epub 2024 Jun 26.
7
Synthetic pentatrideca-valent triazolylsialoside inhibits influenza virus hemagglutinin/neuraminidase and aggregates virion particles.合成五肽十五元环三唑基唾液酸苷抑制流感病毒血凝素/神经氨酸酶并聚集病毒粒子。
Eur J Med Chem. 2023 Nov 5;259:115578. doi: 10.1016/j.ejmech.2023.115578. Epub 2023 Jun 23.
8
Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.I117V 取代介导的神经氨酸酶亚型 H5N1 禽流感 A 病毒奥司他韦耐药的分子机制。
J Infect Dis. 2013 Jan 1;207(1):89-97. doi: 10.1093/infdis/jis633. Epub 2012 Oct 10.
9
Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.神经氨酸酶活性降低会加重2009年大流行性流感病毒感染小鼠的病情。
J Virol. 2016 Oct 14;90(21):9931-9941. doi: 10.1128/JVI.01188-16. Print 2016 Nov 1.
10
Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness.具有 H275Y 奥司他韦耐药性神经氨酸酶突变的 2009 年大流行性 H1N1 流感病毒在酶活性和病毒适应性方面略有降低。
J Antimicrob Chemother. 2011 Mar;66(3):466-70. doi: 10.1093/jac/dkq486. Epub 2010 Dec 16.

引用本文的文献

1
Determination of Oseltamivir in Human Plasma by HPLC-MS/MS.采用高效液相色谱-串联质谱法测定人血浆中的奥司他韦。
Pharm Chem J. 2023;57(1):116-122. doi: 10.1007/s11094-023-02858-5. Epub 2023 Apr 15.
2
Alloferon and Zanamivir Show Effective Antiviral Activity against Influenza A Virus (H1N1) Infection In Vitro and In Vivo.阿洛福韦和扎那米韦对甲型 H1N1 流感病毒在体外和体内均显示出有效的抗病毒活性。
Int J Mol Sci. 2022 Dec 30;24(1):678. doi: 10.3390/ijms24010678.